Skip to content

Drug interactions

Pacritinib + Secobarbital

Severity: Major

Pacritinib and Secobarbital: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Secobarbital may reduce pacritinib exposure by inducing CYP3A4. Pacritinib labeling advises avoiding strong CYP3A4 inducers because efficacy could decline.

What this interaction means in plain words

Pacritinib and Secobarbital can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Pacritinib belongs to Oncology; Secobarbital belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

CYP3A4 induction increases pacritinib metabolism.

What to do

Avoid the combination and use a non-inducing alternative. Monitor spleen volume and symptoms if coadministration is unavoidable.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pacritinib and Secobarbital, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pacritinib with Secobarbital?

MediHelp rates the interaction as major. Pacritinib and Secobarbital can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Secobarbital may reduce pacritinib exposure by inducing CYP3A4. Pacritinib labeling advises avoiding strong CYP3A4 inducers because efficacy could decline.

How serious is the interaction between Pacritinib and Secobarbital?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and use a non-inducing alternative. Monitor spleen volume and symptoms if coadministration is unavoidable.

What other medicines interact with Secobarbital?

MediHelp also lists interactions of Secobarbital with, for example, Calcium / magnesium / potassium / sodium oxybates, Doravirine, Elbasvir / grazoprevir. The full list is on the Secobarbital page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in